Abstract
8543Background: There is significant heterogeneity in the treatment of stage IIIA NSCLC. We evaluated the therapeutic and survival disparities in IIIA NSCLC patients based on the hospital volume us...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
